These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30781374)

  • 1. Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators:
    Martins E; Silva V; Lemos A; Palmeira A; Puthongking P; Sousa E; Rocha-Pereira C; Ghanem CI; Carmo H; Remião F; Silva R
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30781374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat.
    Silva R; Sousa E; Carmo H; Palmeira A; Barbosa DJ; Gameiro M; Pinto M; Bastos Mde L; Remião F
    Arch Toxicol; 2014 Apr; 88(4):937-51. PubMed ID: 24464498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity.
    Silva R; Palmeira A; Carmo H; Barbosa DJ; Gameiro M; Gomes A; Paiva AM; Sousa E; Pinto M; Bastos Mde L; Remião F
    Arch Toxicol; 2015 Oct; 89(10):1783-800. PubMed ID: 25234084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate.
    Vilas-Boas V; Silva R; Palmeira A; Sousa E; Ferreira LM; Branco PS; Carvalho F; Bastos Mde L; Remião F
    PLoS One; 2013; 8(8):e74425. PubMed ID: 23991219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthones as P-glycoprotein modulators and their impact on drug bioavailability.
    Silva V; Gil-Martins E; Silva B; Rocha-Pereira C; Sousa ME; Remião F; Silva R
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):441-482. PubMed ID: 33283552
    [No Abstract]   [Full Text] [Related]  

  • 6. P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies.
    Rocha-Pereira C; Ghanem CI; Silva R; Casanova AG; Duarte-Araújo M; Gonçalves-Monteiro S; Sousa E; Bastos ML; Remião F
    Toxicol Appl Pharmacol; 2020 Jan; 386():114832. PubMed ID: 31756430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal P-glycoprotein inhibitors, benzoxanthone analogues.
    Chae SW; Lee J; Park JH; Kwon Y; Na Y; Lee HJ
    J Pharm Pharmacol; 2018 Feb; 70(2):234-241. PubMed ID: 29238994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies.
    Lopes A; Martins E; Silva R; Pinto MMM; Remião F; Sousa E; Fernandes C
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells.
    Silva R; Carmo H; Dinis-Oliveira R; Cordeiro-da-Silva A; Lima SC; Carvalho F; Bastos Mde L; Remião F
    Arch Toxicol; 2011 Apr; 85(4):315-26. PubMed ID: 20857089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells.
    Silva R; Carmo H; Vilas-Boas V; de Pinho PG; Dinis-Oliveira RJ; Carvalho F; Silva I; Correia-de-Sá P; Bastos Mde L; Remião F
    Toxicol Lett; 2013 Feb; 217(1):34-41. PubMed ID: 23220037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
    Zhang Y; Wang C; Liu Z; Meng Q; Huo X; Liu Q; Sun P; Yang X; Sun H; Ma X; Liu K
    Pharmacol Rep; 2018 Apr; 70(2):243-250. PubMed ID: 29475007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzophenones and xanthone derivatives from Garcinia schomburgkiana-induced P-glycoprotein overexpression in human colorectal Caco-2 cells via oxidative stress-mediated mechanisms.
    Boonyong C; Pattamadilok C; Suttisri R; Jianmongkol S
    Phytomedicine; 2017 Apr; 27():8-14. PubMed ID: 28314481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Intestinal Efflux Transporter Inhibition Activity of Xanthones from Mangosteen Pericarp: An In Silico, In Vitro and Ex Vivo Approach.
    Dechwongya P; Limpisood S; Boonnak N; Mangmool S; Takeda-Morishita M; Kulsirirat T; Rukthong P; Sathirakul K
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
    Chufan EE; Kapoor K; Ambudkar SV
    Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in silico evaluation of P-glycoprotein inhibition through
    Hosseini Balef SS; Piramoon M; Hosseinimehr SJ; Irannejad H
    Chem Biol Drug Des; 2019 Mar; 93(3):283-289. PubMed ID: 30270513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine effect on P-glycoprotein expression and activity: in silico and in vitro studies.
    Silva R; Carmo H; Vilas-Boas V; Barbosa DJ; Palmeira A; Sousa E; Carvalho F; Bastos Mde L; Remião F
    Chem Biol Interact; 2014 Jul; 218():50-62. PubMed ID: 24759273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.
    Silva R; Vilas-Boas V; Carmo H; Dinis-Oliveira RJ; Carvalho F; de Lourdes Bastos M; Remião F
    Pharmacol Ther; 2015 May; 149():1-123. PubMed ID: 25435018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.